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Introduction
Measles is a highly contagious systemic viral infec-
tion caused by the Measles virus (MeV). This virus 
belongs to the Paramyxoviridae family, has ssRNA 
genome and a lipid envelope. It spreads through res-
piratory droplets and also through conjunctiva con-
tact (Khan et al. 2013). Its diagnostic criteria include 
high-grade fever (38°C lasting for > 3 days), generalized 
maculopapular rashes, cough, coryza, and conjunctivi-
tis (WHO 2018a). Measles viral infection is the lead-
ing cause of morbidity and mortality worldwide among 
children, even though there is a safe and effective live 
attenuated viral vaccine (Wolfson et al. 2009). In 2010, 
there were about 20 million measles infections reported 
with 0.14 million deaths (Simons et al. 2012). The death 
toll surged to approximately 0.16 million in 2011, with 
95% of deaths reported from developing countries 
(WHO 2013). Presently, 45 million new measles cases 
were recorded, with one million deaths per year (Li et al. 
2015). In 2011, measles hit 4386 people in Pakistan, with 
64 deaths reported. In 2012, 2,676 laboratory-confirmed 
cases, and 310 deaths were reported in this country 
(Khan and Qazi 2014; CDC 2018). Measles viral infec-
tion is of substantial interest to immunologists due to its 
paradoxical interaction with the immune system. Many 
manifestations of the disease like rashes, conjunctivitis, 
and stomatitis are tagged with the immune response to 
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A b s t r a c t
Measles infection is of substantial interest to immunologists due to its paradoxical interaction with the immune system. After the acquisi-
tion of the measles infection, secondary infection plays a pivotal role in measles-related deaths. A cross-sectional study conducted between 
December 2018 and July 2019 is presented here. A total of one hundred children of both genders presented with measles complications 
were included following WHO criteria. Measles confirmation was done by quantitative determination of anti-measles antibodies (IgM) 
in patients’ sera while patient-related demographic data, vaccination status, and other clinical information were obtained on a separate 
form. The number of female patients (52%) slightly exceeded the number of males (48%). 43% of patients’ parents were illiterate, and half 
of the patients (50%) were from a poor background. The majority of children (76%) who presented with the complications did not receive 
a measles vaccine. 56% of children were breastfed while 58% received vitamin A supplements but developed complications. The elevated 
levels of anti-measles IgM were observed in 77% of cases. In both genders, the major complications were pneumonia, lower respiratory tract 
infection (LRTI), acute diarrhea, diarrhea and LRTI, pneumonia and diarrhea, otitis media and pneumonia, myocarditis and LRTI, and 
pneumothorax. The majority of the infected children (n = 48) under 12 months of age had associated complications. It has been observed 
that the measles virus strikes early age children in the northwestern region of Pakistan, which is an alarming situation and is associated 
with the aforementioned complications, especially in unvaccinated children. Anti-measles IgM is an important serological parameter for 
early diagnosis of measles infection.
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infection. This immune response clears the virus from 
the body, providing lifelong immunity. After the acute 
phase of measles infection, the presence of the viral 
genome and its proteins in the lymphatic tissues leads 
to a suppressed immune system. Furthermore, as the 
immune suppression spans to several weeks, there is an 
opportunity for secondary microbial infections, which 
increase the mortality rate among children (Beckford 
et al. 1985; De Vries et al. 2012).
After measles infection, secondary infections play 
a crucial role in measles-related deaths. Lower respira-
tory tract infections (LRTI) like bronchial pneumo-
nia, are the leading cause of death in measles cases, 
particularly among children under 5 years of age (Li 
et al. 2015). Other serious complications, particularly 
among immunocompromised and malnourished chil-
dren, include blindness, acute diarrhea, otitis media, 
encephalitis, and myocarditis (WHO 2016). One of the 
fatal complications related to measles is sub-acute scle-
rosing panencephalitis (SSPE), which is a progressive, 
disabling, and deadly brain disorder of the central nerv-
ous system, usually developed between 7 and 10 years 
after a person is infected by the measles virus (Bellini 
et al. 2005). In a recent study conducted in Pakistan, 
complications like pneumonia, oral lesions, and acute 
diarrhea were reported due to measles infection among 
unvaccinated children (Hussain et al. 2016). Associ-
ated factors that are instrumental in the generation of 
complications include vitamin A deficiency, weakened 
immunity, living in congested environments, and poor 
access to health care facilities (Sultana et al. 2015).
Developed countries were successful in the reduc-
tion of measles infections through effective immuniza-
tion. Under the auspices of the WHO, a campaign of 
immunization against communicable diseases started 
in Pakistan in 1978 (Bugvi et al. 2006). However, like 
other developing countries, the coverage of measles 
vaccination is below 60% in Pakistan (Mere et al. 2019). 
In preventing and reduction of measles infection and 
associated complications, the only hope is effective 
measles vaccination, which can significantly reduce 
the incidence of measles infection and related deaths 
among children (Gafaar et al. 2003). Unfortunately, 
recent outbreaks of measles infection (in 2018) in Paki-
stan occurred in different regions of the country (WHO 
2019). The primary reasons for these measles episodes 
are lack of awareness regarding vaccination among the 
general population due to reduced literacy rate, lack of 
motivation among health care staff, and poor health 
care infrastructure.
Keeping in view the current scenario, this study 
was designed to investigate the measles incidence and 
its associated complications among the children of 




The present study is a cross-sectional study con-
ducted in the pediatric unit of the Lady Reading Hospital 
(LRH), a tertiary care hospital in District Peshawar, KP. 
Measles cases were defined in accordance with WHO 
criteria (2018), i.e., fever (38°C lasting for more than 
three days) and maculopapular rash, cough, coryza, or 
conjunctivitis. Measles cases were confirmed by detect-
ing measles-specific IgM antibodies (anti-MeV IgM) in 
a patient serum through enzyme-linked immunosorb-
ent assays (ELISA). A total of one hundred measles cases 
were studied for anti-MeV IgM confirmation. Vene-
real blood samples were collected aseptically between 
December 2018 and July 2019 from measles-infected 
children of both genders, above four months of age but 
under ten years, with measles complications and having 
been admitted to the pediatric unit of LRH Peshawar. 
Children aged less than 4 months or over ten years old 
or having congenital heart disease, thalassemia, or other 
congenital diseases were excluded from the study. Mea-
sles complications were diagnosed by physicians based 
on clinical findings with the support of laboratory and 
radiological findings, like X-ray chest, electrocardio-
gram, serum electrolytes, and complete blood count.
Patient demographic data and clinical information 
like age, sex, socio-economic status, educational level of 
parents, feeding history, vitamin A intake, and compli-
cations were recorded on a separate predesigned form. 
The measles vaccination status of a patient was estab-
lished either through a vaccination card or through 
verbal confirmation with parents (if vaccination card 
not available). A written consent form was given to the 
parents, explaining the use of their data for research 
and publication.
Detection of measles-specific IgM antibodies. For 
the detection of measles-specific IgM antibodies, a fresh 
blood sample of about 2 ml from measles-infected chil-
dren was collected by the vein puncture method in a gel 
tube. All the samples were centrifuged at 8,000 rpm in 
order to obtain a clear serum and to send for estimation 
of measles-specific IgM antibodies (ORGENTEC Diag-
nostka Alegria Anti Measles IgM Assay). The measur-
ing range of Alegria assay was 0–200 U/ml. The cut-off 
value for the assay was 25 U/ml. Interpretation of the 
result was as follows: patient value less than 20 U/ml was 
considered negative, while a value between 20–25 U/ml 
was considered borderline, and a value > 25 U/ml was 
considered positive (Alegria Orgentec).
Principle of the assay. Detection of measles-specific 
IgM antibodies was done using Alegria®, a fully auto-
mated random access analyzer. The Alegria® Test Strip 
is designed for a single determination of one patient 
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sample, which holds a complete set of reagents, includ-
ing enzyme conjugate (Anti-human IgM HRP labeled), 
enzyme substrate (Tetramethyle benzidin), sample 
buffer, and a test specific control (Test specific anti-
bodies). Antibodies quantification is based on an indi-
rect enzyme-linked immune reaction in which purified 
particles of inactivated measles virus coated on a well 
surface interact with the corresponding anti-measles 
antibodies present in patient serum. After subsequent 
washing, an enzyme conjugate that binds to the immo-
bilized antibody-antigen complex is added. After incu-
bation, the addition of the enzyme substrate results in 
the development of a blue color, which is proportional 
to the concentration of the antibody-antigen complex 
measured at λ = 650 nm.
Results
Patients’ demographic data (Table I) shows that out 
of 100 patients, 52 (52%) were females with a  mean 
age of 15.06 (± 9.42), while 48 (48%) were males aged 
15.94 (± 9.70). As far as the educational status of the 
parents was concerned, a high percentage (43%) were 
uneducated, while 28% had Grade 10 (Secondary edu-
cation level), and 22% had Grade 5 level (Primary edu-
cation) educational competence. Only 7% of parents 
were found to have beyond Grade 10 level education 
(Higher education).
As far as the socio-economic position is concerned, 
half (50%) of the patients belonged to low-income fami-
lies (≤ $1,700 per annum), while 38% were from mid-
dle-class families (≥ $1,701 and ≤ $4,300 per annum). 
Only 7% of patients were from the upper class (≥ $4,301 
per annum). Criteria of income per annum of the par-
ents were sited, according to Hussain et al. (2016) with 
little modification.
Breast-feeding of babies in this region of Pakistan is 
a common practice in early childhood, although trends are changing. It was observed that 56% of children were breastfed while 32% were given formula milk. A com-
paratively small group of babies (12%) was found to 
be on formula as well as being breast-fed. It was also 
observed that 58% of measles-infected children had 
received vitamin A drops during the routine vaccina-
tion schedule.
The antibody (IgM) levels (Fig. 1) were found to 
be elevated in a majority (77%) of cases, while 8% 
of cases indicated intermediate levels, and 15% were 
found negative for the IgM presence. The measles infec-
tion was found in 76% of children who did not receive 
the vaccination, but 24% of cases were resurgence, 
where children had received one dose of measles vac-
cination (Table I).
The gender distributions of measles-associated com-
plications are given in Fig. 2. In male patients major 






Male 15.06 (± 9.42)




Breast + Formula 12%
Measles vaccination status (%)
Vaccinated (Total) 24%
  < 12 months (n = 2)
  12–24 months (n = 17)
  > 24 months (n = 5)
Unvaccinated (Total) 76%
  < 12 months (n = 42)
  12–24 months (n = 23)
  > 24 months (n = 11)
Vitamin A intake (both genders) 58%
Parents-related
Socio-economic status (%)
High (≥ $4,301 per annum) 12%
Middle (≥ $1,701 and ≤ $4,300 per annum) 38%







Demographic and related data of the patients.
Parameters Patient
Fig. 1. The overall distribution of anti-measles antibody (IgM)
in patients’ sera (n = 100).
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by LRTI (n = 8; 16.7%), acute diarrhea (n = 2; 4.2%), 
diarrhea and LRTI (n = 8; 16.6%), pneumonia and diar-
rhea (n = 3; 6.2%), otitis media and pneumonia (n = 4; 
8.3%), myocarditis and LRTI (n = 2; 4.1%), and pneu-
mothorax (n = 1; 2.0%), respectively. In female patients, 
pneumonia (n = 21; 42.4%) was the major complication 
followed by LRTI (n = 10: 19.2%), otitis media (n = 2; 
3.8%), acute diarrhea (n = 4; 7.7%), diarrhea and LRTI 
(n = 10; 19.2%), pneumonia and diarrhea (n = 3; 5.7%), 
myocarditis and LRTI (n = 1; 1.9%), SSPE (n = 1; 1.9%), 
and pneumothorax (n = 1; 1.9%).
The age distribution (Table II) of clinical complica-
tions showed a high frequency of pneumonia (n = 23; 
47.9%), followed by LRTI (n = 8; 16.7%), acute diarrhea 
(n = 4; 8.3%), diarrhea and LRTI (n = 6; 12.5%), pneu-
monia and diarrhea (n = 3; 6.25%), otitis media and 
pneumonia (n = 2; 4.1%), myocarditis and LRTI (n = 1; 
2%), and pneumothorax (n = 1; 2%) in patients less than 
12 months old. While for the age group 12–24 months, 
pneumonia (n = 15; 37.5%) was the major complica-
tion, followed by LRTI (n = 8; 20%), otitis media (n = 1; 
2.5%), acute diarrhea (n = 1; 2.5%), diarrhea and LRTI 
(n = 8; 20.0%), pneumonia and diarrhea (n = 2; 5%), 
otitis media and pneumonia (n = 1; 2.5%), myocarditis 
and LRTI (n = 2; 5%), SSPE (n = 1; 2.5%) and pneumo-
thorax 1 (2.5%). Complications presentation for the age 
group > 24 months were predominated by pneumonia 
(n = 3; 25%) and diarrhea + LRTI (n = 3; 25%), followed 
by LRTI (n = 2; 16.7%), otitis media (n = 1; 8.3%), acute 
diarrhea (n = 1; 8.3%), pneumonia and diarrhea (n = 1; 
8.3%) and otitis media and pneumonia (n = 1; 8.3%). In 
the current study, the majority of the children (n = 76) 
Pneumonia 23 (47.9%) 15 (37.5%)  3 (25%) 41
LRTI  8 (16.7)  8 (20)%  2 (16.7%) 18
Otitis media   –  1 (2.5%)  1 (8.3%) 2
Acute diarrhea  4 (8.3%)  1 (2.5%)  1 (8.3%) 6
Diarrhea + LRTI*  6 (12.5%)  8 (20%)  3 (25%) 17
Pneumonia + Diarrhea  3 (6.25%)  2 (5%)  1 (8.3%) 6
Otitis media + Pneumonia  2 (4.1%)  1 (2.5%)  1 (8.3%) 4
Myocarditis + LRTI  1 (2.0%)  2 (5%)   – 3
SSPE†   –  1 (2.5%)   – 1
Pneumothorax  1 (2.0%)  1 (2.5%)   – 2
Total 48 40  12 100
Table II
Frequency and distribution of measles complications in different age groups of patients
* LRTI – Lower respiratory tract infection
† SSPE – Subacute sclerosing panencephalitis
Clinical complications
Age-wise distribution
< 12 months 12–24 months > 24 months Total
Fig. 2. Gender distribution of measles complications (Percentage).
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suffering from measles complications were unvacci-
nated, while only 24 children who had received one 
dose of measles vaccination were shown in Fig. 4.
Discussion
Measles is a highly contagious viral disease that 
leads to increased morbidity and mortality among 
children, especially in developing countries. Measles 
infection has the potential to lead to life-threatening 
complications (Filia et al. 2013).
Eradication of measles is an crucial section of Mil-
lennium Development Goal 4 of the WHO. Pakistan, as 
a member of the Eastern Mediterranean Region, agreed 
in 1997 to eliminate measles infection by 2010 (Gafaar 
et al. 2003). Unfortunately, the resurgence of measles is 
continuously reported from different regions of Pakistan 
over the last decade. According to a WHO 2019 report, 
during 2011, 2012, and 2013, the number of confirmed 
measles cases in Pakistan was 2,676, 8,048, and 8,030, 
respectively. More recently, in 2017 and 2018, significant 
measles episodes were reported throughout the country 
(Fig. 3). According to the Pakistan demographic health 
survey and social living standard measurement, the 
Expanded Program on Immunization (EPI) coverage 
is currently 65% and each year about 2 million Pakistani 
children do not receive their first dose of measles vacci-
nation, while the coverage of the second dose of measles 
is lower (< 60%) (CDC 2018).
The upsurge of measles in Pakistan could be attrib-
uted to several factors. Graft in the healthcare system, 
which encompasses illicit allocation of funds, poor 
attitude of healthcare workers, quackery, fake vaccina-
tion campaigns, and marketing of expired drugs, plays 
a central role. Another hurdle is dissatisfactory health 
infrastructure in the country contributes to the resur-
gence of measles outbreaks (Islam et al. 2019).
Detection of measles-specific immunoglobulin 
(IgM), produced as a result of the primary immune 
response, serves as the gold standard in accurate diag-
nosis of measles infection. These antibodies are easily 
detected in patient serum within a few days after the 
onset of the rashes through an enzyme-linked immu-
nosorbent-based assay (Xavier et al. 2019). In the cur-
rent study, the WHO-recommended ELISA technique 
was used for the detection of serum antibodies with 
77% positive results (Patient value > 25 IU). Grey zone 
or borderline titers, i.e., values between 20–25 IU, were 
observed in 8% cases, while 15% of cases were negative 
(Patient value < 20 IU). The borderline titers or seron-
egative results may be attributed to inadequate immune 
responses of the host or maybe due to early blood sam-
ple collection before elevated IgM level in the serum 
of the respective patients. IgM may also be negative 
in a true measles case if the specimen is collected too 
early or too late in the course of the illness. In the first 
72 hours after rash onset, a negative result for measles 
IgM may be obtained from up to 30% of measles cases. 
The sensitivity of the test is lower ≤ three days after rash 
onset (WHO 2018b). The vitamin A deficiency often 
leads to increase in the risk of blindness among the 
measles-infected children. In the present study, vitamin 
A had been administered in 58% of measles-infected 
Fig. 3. Number of confirmed measles cases from 2006 to 2019 in Pakistan (WHO 2019; updates).
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children, although vitamin A administration is not 
a regular part of the vaccine schedule followed in Paki-
stan. Poor immune response, improper maintenance 
of cold chain during transportation, and neglectful 
attitude of health care staff may be factors leading to 
the development of complications. In the present study, 
vitamin A intake information was made through verbal 
communication with the parents of the children.
The age-wise distribution, status of vaccination, and 
incidence of measles infection for the period Septem-
ber 2018 to August 2019 in Pakistan was given in 2019 
WHO report. The findings suggest an emergency and 
the need for quick intervention. Furthermore, prompt 
education on the awareness and benefits of immuni-
zation among the population of this region is needed.
In the present study, pneumonia (41%) and diarrhea 
were the major complications associated with measles 
infection, and these observations are similar to a report 
by Khan et al. (2013), while in a separate study con-
ducted by Rashid et al. (2016), a slightly high frequency 
for the complications mentioned above was reported. 
In the present study, co-infections like diarrhea with 
LRTI, pneumonia and diarrhea, otitis media and pneu-
monia, and myocarditis and LRTI were observed. In 
the present study, the vaccination status of the measles-
infected children was established through vaccination 
cards issued by EPI Health department KP, Pakistan. 
The vaccination status of the patients was confirmed 
through a vaccination card in more than 80 children. 
Only for a few children was vaccination status con-
firmed by parents through verbal communication. 
Negligence, low education status, and less awareness 
about vaccination schedules among the parents deter-
mine their mindset regarding the prevention of measles 
in this region. It is evident from the present study that 
significant factors that may contribute to the resurgence 
of measles infections include low vaccination (24 vacci-
nated babies versus 76 unvaccinated) that may be due to 
lack of vaccination awareness, poor health infrastruc-
ture, malnutrition, and missing of a booster dose. Mal-
nutrition is a significant risk factor in measles-infected 
children around acquiring complications that lead to 
increased mortality among unvaccinated children. Fur-
thermore, the majority of the infected children (76%) 
were not vaccinated, which highlights the higher risk 
of acquiring infection and resultant complications. 
In a  report by Husain et al. (2016), 75% of children 
with pneumonia were malnourished, while 83.3% of 
such children also had diarrhea. In the present study, 
children under one year of age, particularly between 
7–8  months, developed measles complications. The 
principal reason behind this may be the underdevel-
oped immune system that makes children more prone 
to this disease and its subsequent complications.
In Pakistan, the vaccination schedule for measles 
vaccination is nine months, while the booster dose is at 
14 or 15 months (Table III). For this disease, it has been 
recommended that the administration of booster dose 
be made at 14 to 15 months of age, increasing the vac-
cine efficacy up to 99% and providing more protection 
compared to a single dose (De Serres et al. 2012). How-
ever, in the present research, we did not observe any 
booster dose administration for the children infected 
by measles. It is an alarming finding that necessitates 
Fig. 4. Distribution of measles complications among measles-vaccinated and unvaccinated children.
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a mandatory administration of the primary as well as 
the booster dose among children.
Measles remains a leading cause of death among 
young children worldwide despite the availability of 
a live attenuated effective vaccine. In the present study, 
severe complications like pneumonia, acute diarrhea, 
myocarditis, and pneumothorax were observed in chil-
dren under one year of age. Only one case of SSPE was 
observed that was confirmed through the detection of 
anti-measles antibodies in cerebrospinal fluid (CSF) 
of the patient. The number of children with SSPE may 
be underestimated; generally, it is developed 7–10 years 
after a person has measles, even though the person 
seems to have fully recovered from the illness.
Multiple outbreaks of measles have been reported 
from different parts of the world (Wolfson et al. 2009) 
and particularly from this region of Pakistan. It is not 
only worrisome but needs an effective strategy in the 
health care system to devise a national strategy for mea-
sles vaccinations. Combined efforts of the health care 
staff, awareness through social media, and related health 
professionals are required to augment awareness among 
the general public regarding the vaccination program 
and clinical consequences of measles infection in order 
to prevent the disease from resurging as endemic.
Conclusions
The measles virus has potentially fatal consequences 
at an early age of childhood, not only in Pakistan but 
worldwide, which is alarming. Major complications 
observed in the present case included pneumonia, LRTI, 
diarrhea, otitis media, myocarditis, and SSPE, with some 
patients presenting more than one complication. Pri-
marily, the complications were observed among unvac-
cinated and among children vaccinated only with one 
dose of vaccine, which illustrates the importance of the 
measles vaccination. Moreover, the booster dose admin-
istration can be made mandatory in order to achieve 
better immunization. Furthermore, the workhorse 
method proved to be significant and can be effectively 
utilized in the early diagnosis of measles infection.
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